Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (131-140 of 434) with videos related to

Pageof 44
Sort By:
The Journal of Urology|March 11, 2005
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyAntoine G van der Heijden, Gerald Verhaegh, Cornelius F J Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
BJU International|January 18, 2019
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancerDavid D'Andrea, Francesco Soria, Sonja Zehetmayer, et al.
European Urology Oncology|June 20, 2020
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the FutureMalte W Vetterlein, J Alfred Witjes, Yohann Loriot, et al.
International Journal of Cancer|July 1, 2014
The prognostic value of family history among patients with urinary bladder cancerLieke Egbers, Anne J Grotenhuis, Katja K Aben, et al.
European Urology|May 20, 2014
Reply to Sarah Willis, Alec Miners, and Jan van der Meulen's letter to the editor re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012Maarten de Rooij, Simone Crienen, J Alfred Witjes, et al.
European Urology|June 21, 2005
The efficacy of different follow-up strategies in clinical stage I Non-seminomatous Germ Cell Cancer: a Markov simulation studyJesse Roan Spermon, Aswin L Hoffmann, Simon Horenblas, et al.
European Urology|May 3, 2011
The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic reviewRianne J M Lammers, J Alfred Witjes, Brant A Inman, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2009
Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stageJustine Varinot, Philippe Camparo, Morgan Roupret, et al.
Family Practice|October 11, 2013
Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testingEsther Hj Hamoen, Daphne Fm Reukers, Mattijs E Numans, et al.
Pageof 44

Showing results (131-140 of 434) with videos related to

Sort By:
Pageof 44
The Journal of Urology|March 11, 2005
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyAntoine G van der Heijden, Gerald Verhaegh, Cornelius F J Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
BJU International|January 18, 2019
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancerDavid D'Andrea, Francesco Soria, Sonja Zehetmayer, et al.
European Urology Oncology|June 20, 2020
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the FutureMalte W Vetterlein, J Alfred Witjes, Yohann Loriot, et al.
International Journal of Cancer|July 1, 2014
The prognostic value of family history among patients with urinary bladder cancerLieke Egbers, Anne J Grotenhuis, Katja K Aben, et al.
European Urology|May 20, 2014
Reply to Sarah Willis, Alec Miners, and Jan van der Meulen's letter to the editor re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012Maarten de Rooij, Simone Crienen, J Alfred Witjes, et al.
European Urology|June 21, 2005
The efficacy of different follow-up strategies in clinical stage I Non-seminomatous Germ Cell Cancer: a Markov simulation studyJesse Roan Spermon, Aswin L Hoffmann, Simon Horenblas, et al.
European Urology|May 3, 2011
The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic reviewRianne J M Lammers, J Alfred Witjes, Brant A Inman, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2009
Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stageJustine Varinot, Philippe Camparo, Morgan Roupret, et al.
Family Practice|October 11, 2013
Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testingEsther Hj Hamoen, Daphne Fm Reukers, Mattijs E Numans, et al.
Pageof 44